BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4521800)

  • 1. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.
    Watson CJ; Bossenmaier I; Cardinal R; Petryka ZJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):278-82. PubMed ID: 4521800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria.
    Eriksen L; Eriksen N
    Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698
    [No Abstract]   [Full Text] [Related]  

  • 3. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.
    Bonkowsky HL; Tschudy DP; Collins A; Doherty J; Bossenmaier I; Cardinal R; Watson CJ
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2725-9. PubMed ID: 5288250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family study in congenital erythropoietic porphyria.
    Darocha T; Weremowicz J; Gregor A
    S Afr Med J; 1971 Sep; ():231-7. PubMed ID: 5150286
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital erythropoietic porphyria with a hitherto undescribed porphyrin pattern.
    Hofstad F; Seip M; Eriksen L
    Acta Paediatr Scand; 1973 Jul; 62(4):380-4. PubMed ID: 4729688
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on porphyrin biosynthesis and enzymes involved in bovine congenital erythropoietic porphyria.
    Del Batlle AM; De Xifra EA; Stella AM; Bustos N; With TK
    Clin Sci (Lond); 1979 Jul; 57(1):63-70. PubMed ID: 477249
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of various therapeutic trials on the prophyrin excretion in a case of congenital erythropoietic prophyria.
    Eriksen L; Seip M
    Acta Paediatr Scand; 1975 Mar; 64(2):287-92. PubMed ID: 1130187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital erythropoietic porphyria. The effect of light shielding.
    Eriksen L; Hofstad F; Seip M
    Acta Paediatr Scand; 1973 Jul; 62(4):385-90. PubMed ID: 4729689
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital erythropoietic porphyria. II. The effects of induced polycythemia.
    Haining RG; Cowger ML; Labbe RF; Finch CA
    Blood; 1970 Sep; 36(3):297-309. PubMed ID: 5451921
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital erythropoietic porphyria. I. Case report, special studies and therapy.
    Haining RG; Cowger ML; Shurtleff DB; Labbe RF
    Am J Med; 1968 Oct; 45(4):624-37. PubMed ID: 5678101
    [No Abstract]   [Full Text] [Related]  

  • 11. Porphyrin production and liver involvement in a patient with erythropoietic protoporphyria.
    Romslo I; Høvding G; Hamre E; Laerum OD
    Scand J Clin Lab Invest; 1978 Oct; 38(6):529-35. PubMed ID: 705235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal.
    Tishler PV; Winston SH
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):645-8. PubMed ID: 2084460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte porphyrin and erythrocyte survival in bovine erythropoietic porphyria.
    Kaneko JJ; Zinkl JG; Keeton KS
    Am J Vet Res; 1971 Dec; 32(12):1981-5. PubMed ID: 5131421
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic protoporphyrin production in human protoporphyria. Effects of intravenous hematin and analysis of erythrocyte protoporphyrin distribution.
    Lamon JM; Poh-Fitzpatrick MB; Lamola AA
    Gastroenterology; 1980 Jul; 79(1):115-25. PubMed ID: 7380207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital erythropoietic porphyria. A case report with discussion of different porphyrin excretion patterns.
    Dahle JS; Eriksen L; Romslo I; Thune P
    Photodermatol; 1984 Aug; 1(4):187-90. PubMed ID: 6531292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria.
    Grandchamp B; Deybach JC; Grelier M; de Verneuil H; Nordmann Y
    Biochim Biophys Acta; 1980 May; 629(3):577-86. PubMed ID: 7417513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions.
    Piomelli S; Poh-Fitzpatrick MB; Seaman C; Skolnick LM; Berdon WE
    N Engl J Med; 1986 Apr; 314(16):1029-31. PubMed ID: 3960070
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma porphyrin concentrations in porphyria cutanea tarda.
    Moore MR; Thompson GG; Allen BR; Hunter JA; Parker S
    Clin Sci Mol Med; 1973 Nov; 45(5):711-4. PubMed ID: 4759516
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietic protoporphyria: therapeutic response to combined erythrocyte exchange and plasmapheresis.
    Spiva DA; Lewis CE
    Photodermatol; 1984 Oct; 1(5):211-20. PubMed ID: 6531299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria.
    Pimstone NR; Gandhi SN; Mukerji SK
    N Engl J Med; 1987 Feb; 316(7):390-3. PubMed ID: 3100953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.